Vaylen vs Maximus: Compounded GLP-1 Plans Compared
Short answer: Vaylen and Maximus both sell compounded GLP-1 care online, but Vaylen emphasizes lower prepaid 12-month rates, multiple formats including oral semaglutide and tirzepatide, and a pay-first model with a refund if a clinician declines; Maximus offers a straightforward $132.99/month flat rate for compounded semaglutide prescribed by licensed doctors, with a smaller public track record. Early verdict: choose Vaylen if you value the lowest effective monthly price and multiple molecule formats; choose Maximus if you prefer a simple monthly flat price with pharmacy fulfillment through trusted U.S. pharmacies.
See Vaylen pricing and formats
Vaylen vs Maximus: how their models differ
This comparison focuses on the most distinctive differences supported by the suppliers: pricing and billing model, medication formats and molecules, geographic availability and clinician process, shipping and turnaround, and refund or approval policies. The primary keyword Vaylen vs Maximus appears in this heading and guides the direct comparisons below.
1. Pricing and billing model
Vaylen publishes headline rates as annualized, prepaid plans and also shows month-to-month rates. For semaglutide Vaylen lists $83.25/mo on the 12-month plan billed upfront or $224/mo month to month. Vaylen states every 12-month rate is billed in a single charge. Maximus offers a low flat rate at $132.99/month on a direct-pay monthly model. Both are cash-pay and do not bill insurance according to their disclosures.
2. Medication formats and molecules
Vaylen sells compounded GLP-1s across three formats and two molecules: weekly semaglutide injections from $83.25/mo on the 12-month plan, daily oral semaglutide tablets at $99/mo prepaid, and weekly tirzepatide from $149/mo prepaid. Vaylen highlights that both molecules and a needle-free format are available on one platform. Maximus focuses on once-weekly compounded semaglutide injections at $132.99/mo and does not publish the same breadth of formats or clear tirzepatide options.
3. Clinician review, approvals, and refunds
Vaylen requires prepayment before a clinician review, then states a board-certified U.S. clinician reviews the health form within 24 hours and Vaylen will issue a full refund for that billing cycle if the clinician declines to prescribe. Maximus states prescriptions are approved by licensed doctors and that if you are not approved for treatment your medication costs will be fully refunded. Both providers disclose that their medications are compounded and not FDA-approved finished products.
4. Availability, shipping, and turnaround
Vaylen notes licensed coverage in all 50 states and free discreet shipping in 1 to 3 business days. Maximus states its program is available in all 50 states except Mississippi, and it advertises free priority or expedited shipping and fulfillment through trusted U.S. pharmacies. These availability details differ and may affect access depending on your state.
5. Track record and platform size
Vaylen markets clinician turnaround within 24 hours and emphasizes platform features like 24/7 care-team messaging included. Maximus describes itself as a smaller platform with a thinner public track record and fewer public reviews, while highlighting licensed doctors and U.S. pharmacy compounding. The evidence supplied does not include independent outcome data beyond published averages cited by each provider.
Comparison table: Vaylen vs Maximus
| Criteria | Vaylen | Maximus |
|---|---|---|
| Headline semaglutide price | $83.25/mo on 12-month plan or $224/mo month to month | $132.99/mo flat rate |
| Medication formats | Injectable semaglutide, oral semaglutide tablets, tirzepatide | Once-weekly semaglutide injections (compounded) |
| Billing model | Prepay annual plans (single charge) or month to month | Direct-pay monthly flat rate |
| Clinician review and refund | Clinician review within 24 hours; full refund if declined | Prescriptions approved by licensed doctors; full refund if not approved |
| Geographic availability | Licensed in all 50 states | Available in all 50 states except Mississippi |
| Shipping | Free discreet shipping in 1 to 3 business days | Free priority or expedited shipping from U.S. pharmacies |
What is not supplied
The supplied sources do not include independent clinical outcome verification specific to each platform beyond general study averages cited, nor do they publish full terms for unused portions of prepaid years at Vaylen. If those details matter to you, they are not supplied in the provided evidence.
Bottom line and who should choose which provider
Vaylen vs Maximus reduces to a choice between a prepaid multi-format platform and a simple monthly semaglutide plan. Vaylen: lower effective monthly headline rates on 12-month prepaid plans, multiple formats including oral semaglutide and tirzepatide, clinician review within 24 hours, free discreet 1 to 3 day shipping, and a stated full refund if a clinician declines. Maximus: a straightforward $132.99/month compounded semaglutide program, prescriptions approved by licensed doctors, fulfillment via trusted U.S. pharmacies, free expedited shipping, and availability in most states except Mississippi.
Compare Vaylen plans in detail
Choose Vaylen if you want the lowest effective monthly headline rate under a prepaid 12-month plan, needle-free oral semaglutide as an option, or access to tirzepatide on the same platform, and you accept prepaying before clinician review with Vaylen’s stated full refund if declined. Choose Maximus if you prefer a simple predictable $132.99/month direct-pay semaglutide program prescribed by licensed doctors and filled through trusted U.S. pharmacies, and you are comfortable with a smaller platform available in all states except Mississippi.